Entactogen Effects of Ketamine: A Reverse-Translational Study.
Evan M Hess, Dede K Greenstein, Olivia L Hutchinson, Carlos A Zarate, Todd D Gould
The American journal of psychiatry September 1, 2024 DOI: 10.1176/appi.ajp.20230980 via PubMed
Summary
AI-generated from the abstractKetamine increases pleasure from social situations in people with treatment-resistant depression and promotes helping behavior in rats. In a randomized, double-blind, placebo-controlled study, participants who received a single intravenous dose of ketamine (0.5 mg/kg) reported greater pleasure from being with family or close friends, seeing smiling faces, helping others, and receiving praise for up to one week after treatment, compared to those given placebo. In a rodent experiment, ketamine-treated rats were more willing to forgo obtaining sucrose to protect a cage mate from electric shock, maintaining lower response rates for six days and delivering fewer shocks overall. These findings indicate that ketamine has prosocial, entactogen effects.
Study at a glance
| Characteristics | Randomized controlled trial Placebo-controlled Double-blind Peer reviewed |
|---|---|
| Population | Participants with treatment-resistant depression |
| Intervention | Ketamine |
| Dose | 0.5 mg/kg intravenously |
| Duration | 1 week posttreatment |
| Topics | Esketamine |
| Keywords | Depressive disorders Entactogens Ketamine/esketamine #ketamine ketamine therapy Special k |
| Citations | 12 |
| Key finding | Ketamine increased pleasure from social situations in patients with treatment-resistant depression and promoted helping behavior in rats, suggesting entactogen effects. |
Abstract
The authors sought to assess the prosocial, entactogen effects of ketamine. Pleasure from social situations was assessed in a sample of participants with treatment-resistant depression from randomized, double-blind, placebo-controlled studies, using four items of the Snaith-Hamilton Pleasure Scale (SHAPS) at five time points over 1 week following treatment with ketamine (0.5 mg/kg intravenously) or placebo. The primary endpoint was postinfusion self-reported pleasure on the four SHAPS items pertaining to social situations, including the item on helping others, between the ketamine and placebo groups. In a rodent experiment, the impact of ketamine on helping behavior in rats was assessed using the harm aversion task. The primary endpoint was a reduction in lever response rate relative to baseline, which indicated the willingness of rats to forgo obtaining sucrose to help protect their cage mate from electric shock. Relative to placebo, ketamine increased ratings of feeling pleasure from being with family or close friends, seeing other people's smiling faces, helping others, and receiving praise, for 1 week following treatment. In the rodent experiment, during the harm aversion task, ketamine-treated rats maintained lower response rates relative to baseline to a greater extent than what was observed in vehicle-treated rats for 6 days posttreatment and delivered fewer shocks overall. In patients with treatment-resistant depression, ketamine treatment was associated with increased pleasure from social situations, such as feeling pleasure from helping others. Ketamine-treated rats were more likely to protect their cage mate from harm, at the cost of obtaining sucrose. These findings suggest that ketamine has entactogen effects.